Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
Online dating has revolutionized dating by creating more opportunities to meet partners than ever before.
Read Full NewsA yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.
A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.
The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.
1.
examining differences in the rates of breast reconstruction following mastectomies.
2.
Hyponatremia Risk Varies Among Second-Gen Antipsychotics
3.
FET-PET Agent Approved for Glioma Imaging
4.
A large study found that monolayers were superior in detecting cancer.
5.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
1.
Hematology Laboratory Simulation: Advancing Clinical Competence through Technology-Driven Training
2.
Innovative Solutions in Hematology for Specialists
3.
Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms
4.
Oncology in High-Risk Populations: Prevention, Screening and Early Detection in Hereditary and Sex-Specific Cancers
5.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Modern Cancer Treatment
2.
Understanding Risk Factors Associated With Common Cancers
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge